SCHEMBL5521636

SCHEMBL5521636

COC(=O)[C@@H]1CC[C@@H](C(N)=O)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.39
HSD17B10 Q99714 1/20 0.38
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
PTPN1 P18031 1/20 0.36
PDE4B Q07343 2/20 0.36
HTRA1 Q92743 1/20 0.35
KMT2A Q03164 1/20 0.35
BRD4 O60885 1/20 0.35
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
HPGD P15428 1/20 0.34
NPC1 O15118 1/20 0.34
SCN4A P35499 1/20 0.33
STS P08842 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5521633 1.00 SMN1; SMN2 (0.39) SMN1; SMN2HSD17B10NR1H2NR1H3PTPN1
SCHEMBL5521638 1.00 SMN1; SMN2 (0.39) SMN1; SMN2HSD17B10NR1H2NR1H3PTPN1
SCHEMBL3240371 0.90 SMN1; SMN2 (0.41) SMN1; SMN2HSD17B10NR1H2NR1H3PTPN1
SCHEMBL7874236 0.89 SMN1; SMN2 (0.40) SMN1; SMN2HSD17B10NR1H2NR1H3PTPN1
SCHEMBL2680322 0.89 SMN1; SMN2 (0.40) SMN1; SMN2HSD17B10NR1H2NR1H3PTPN1
SCHEMBL408875 0.87 SMN1; SMN2 (0.44) SMN1; SMN2HSD17B10NR1H2NR1H3PTPN1
SCHEMBL5505807 0.87 SMN1; SMN2 (0.44) SMN1; SMN2HSD17B10NR1H2NR1H3PTPN1
SCHEMBL26581440 0.82 MMP2 (0.43) SMN1; SMN2HSD17B10NR1H2NR1H3PTPN1
SCHEMBL3299171 0.81 TSHR (0.43) SMN1; SMN2HSD17B10NR1H2NR1H3PTPN1
SCHEMBL599499 0.81 TSHR (0.43) SMN1; SMN2HSD17B10NR1H2NR1H3PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799676-A2 NEW BICYCLIC ANTIBIOTICS Actelion Pharmaceuticals Ltd. (CH) 2007-06-27 EP disclosed
WO-2006032466-A2 NEW BICYCLIC ANTIBIOTICS ACTELION PHARMACEUTICALS LTD (CH) 2006-03-30 WO disclosed